FT Options’s Bausch Health BHC Stock Holding History

FT Options’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,000	Closed	-$24K	–	199
2017 Q1	$22K	Sell	2,000 -3,182	-61%	-$43.8K	0.03%	195
2016 Q4	$75K	Buy	+5,182	New	+$95.1K	0.09%	117

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FT Options's BHC Position: Q2 2017 in Review

FT Options sold out of Bausch Health (BHC) in Q2 2017, closing a stake of 2,000 shares — an estimated $24K sold.

FT Options first reported a position in BHC in Q4 2016 and held it in 2 quarters. The position peaked at $75K in Q4 2016. 317 funds tracked by Wall St. Rank hold BHC as of Q2 2017.

FT Options reported no remaining Bausch Health position as of Q2 2017 after selling out during the quarter.
FT Options sold 2,000 Bausch Health shares in Q2 2017, an estimated $24K.
FT Options first reported a position in Bausch Health in Q4 2016 and held it in 2 quarters.
FT Options's Bausch Health position peaked at $75K in Q4 2016.
317 funds tracked by Wall St. Rank held Bausch Health as of Q2 2017.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.